The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

12 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
A potent and selective inhibitor targeting human and murine 12/15-LOX.EBI
University of California
Inhibitory and mechanistic investigations of oxo-lipids with human lipoxygenase isozymes.EBI
University of California
Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies.EBI
Harvard Medical School
Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase.EBI
National Institutes of Health
Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.EBI
National Human Genome Research Institute
Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1.EBI
National Human Genome Research Institute
Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.EBI
Universidad De Santiago De Chile
Docking and mutagenesis studies lead to improved inhibitor development of ML355 for human platelet 12-lipoxygenase.EBI
University of California Santa Cruz
Kinetic and structural investigations of novel inhibitors of human epithelial 15-lipoxygenase-2.EBI
University of California Santa Cruz
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.EBI
Osaka University